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I. SUMMARY 
________________________________________________________________________ 
Introduction: This health consultation was conducted because some residents of 
communities served by the Mount Greylock Regional School – Hancock, 
Lanesborough, New Ashford, and Williamstown – expressed concerns 
about the occurrence of thyroid cancer in their communities. In addition, 
residents have expressed concern about a possible link between historical 
perchlorate contamination in Wells #1 and #2 formerly used for drinking 
water for the Mount Greylock Regional School and thyroid cancer and 
thyroid disease in the communities.  Perchlorate was discovered in the 
wells in 2004 and, upon learning of the contamination, bottled water was 
used at the school for drinking and cooking.  
________________________________________________________________________ 
Overview:  The MDPH has reached two important conclusions about the incidence of 
thyroid cancer in Hancock, Lanesborough, New Ashford, and 
Williamstown and potential historical exposures to perchlorate-
contaminated well water at the Mount Greylock Regional School.   
________________________________________________________________________ 
Conclusion 1: The MDPH concluded that, based on available historical information, 
potential exposures by ingesting drinking water from Wells #1 and #2 by 
Mount Greylock Regional School staff and students would not be 
expected to have harmed people’s health.  
  
Basis for Decision: Historical sampling of Wells #1 and #2 on the Mount Greylock Regional 
School grounds in 2004 and 2005 showed the presence of perchlorate 
contamination. When the contamination was discovered, bottled water was 
used by the school for drinking and cooking. However, the wells had been 
previously used as the source of drinking water for the high school. It is 
not known how long the contamination was in the wells; the source was 
presumed to be fireworks launched on the school grounds between 1989-
1992 and 1999-2003. Based on perchlorate sampling data from 2004 and 
2005 for Wells #1 and #2 and conservative exposure assumptions, 
noncancer health effects would not be expected. The reason for this is that 
the levels estimated to get into an adult’s or student’s body would be 
below levels that would harm their health.   
________________________________________________________________________ 
Conclusion 2: The MDPH concluded that the incidence of thyroid cancer in Hancock, 
Lanesborough, New Ashford, and Williamstown over the 27-year period 
of 1982 through 2008 does not appear unusual. The incidence of thyroid 
cancer in the four communities was approximately as expected based on 
the statewide thyroid cancer experience. It is important to note that, based 
on a consensus of medical and epidemiological experts, perchlorate is not 
thought to be a potential cancer-causing substance. 
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Basis for Decision: To determine whether the incidence of thyroid cancer in Hancock, 
Lanesborough, New Ashford, and Williamstown was elevated, the 
observed number of thyroid cancer diagnoses in each community was 
compared to the number that would be expected based on the statewide 
cancer rate.  Overall, the numbers of observed diagnoses of thyroid cancer 
in the four communities were approximately as expected for each of the 
four communities. In addition, no unusual trends emerged when the 
overall age, gender and spatial patterns were examined in more detail.    
________________________________________________________________________ 
Next Steps:  The MDPH recommends no further investigation into historical 
perchlorate contamination associated with two former wells located on the 
grounds of the Mount Greylock Regional School and no further 
investigation of thyroid cancer incidence in Hancock, Lanesborough, New 
Ashford, and Williamstown at this time.    
________________________________________________________________________ 
For More Information: If you have concerns about your health, you should contact your 
health care provider.  You may also call the MDPH at 617-624-
5757 and ask for information on the Mount Greylock Regional 
School investigation.   
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II. INTRODUCTION  
At the request of some concerned residents, the Community Assessment Program (CAP) 
of the Massachusetts Department of Public Health (MDPH), Bureau of Environmental 
Health (BEH), reviewed the incidence of thyroid cancer in the communities of Hancock, 
Lanesborough, New Ashford, and Williamstown1.  Concerns focused on a perceived 
increase in the number of individuals with thyroid cancer in these communities as well as 
in staff and students affiliated with the Mount Greylock Regional School. In addition, 
residents expressed concern that perchlorate contamination of two bedrock wells serving 
the Mount Greylock Regional School might have adversely affected the health of the 
students and staff.  The contamination was discovered in April 2004 and, upon discovery 
of the contamination, bottled water was used at the school for drinking and cooking. 
This Health Consultation (HC) provides thyroid cancer incidence data for the four 
communities of Hancock, Lanesborough, New Ashford, and Williamstown. Mount 
Greylock Regional School serves students in grades 7 through 12 from these four 
communities.  In addition, information is presented on what is known about the 
perchlorate contamination that was discovered in 2004 in the school well water, the 
toxicity of perchlorate, and the potential health risks associated with exposure to 
perchlorate at the levels detected in the school wells. 
III. BACKGROUND 
In 2004, the Massachusetts Department of Environmental Protection (MassDEP) 
promulgated emergency regulations requiring public water supplies to test for the 
chemical perchlorate. Perchlorate is an inorganic chemical used as an oxidizer in solid 
propellants for rockets, missiles, fireworks, and explosives. It is a primary component of 
fireworks and explosives. In its draft report The Occurrence and Sources of Perchlorate 
in Massachusetts (MassDEP 2006a), MassDEP reported that, of the 591 water supplies in 
Massachusetts tested for perchlorate at that time, 12 sources in 9 water supply systems 
                                                          
1 This report was supported in part by funds from a cooperative agreement with the Agency for Toxic 
Substances and Disease Registry (ATSDR), U.S. Department of Health and Human Services.  This 
document has not been reviewed and cleared by ATSDR. 
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had perchlorate above the MassDEP drinking water health advisory of 1 microgram per 
liter (μg/L) or 1 part per billion (ppb). (Since then, MassDEP has promulgated a 
perchlorate drinking water standard of 2 ppb.) 
Two bedrock wells servicing the Mount Greylock Regional School in Williamstown were 
tested between April 2004 and February 2005 and found to contain concentrations of 
perchlorate above the MassDEP health advisory of 1 ppb.  Eight samples from Well #1 
had perchlorate levels ranging from 5.05 to 11 ppb. During this same time period, eight 
samples from Well #2 had perchlorate levels ranging from 0.46 to 2.8 ppb (MassDEP 
2006b). Fireworks were launched from the school grounds between 1989 and 1992, and 
from 1999 to 2003 (MassDEP 2006a) and were presumed to be the source of the 
perchlorate.  
Once the contamination was found in 2004, bottled water was supplied to the school for 
drinking and cooking. The school immediately removed Well #1 from service and 
switched to Well #2 for non-drinking and non-cooking purposes.  Health notices were 
posted at water access points (bubblers, bathroom faucets, kitchen faucets, ice machines, 
and outside faucets). The ban on the use of Well #2 for drinking and cooking was lifted 
by the MassDEP in May 2005, based on monitoring data showing that the levels of 
perchlorate in water from Well #2 were below the health advisory of 1 ppb.  Since 
August 2006, the school has relied exclusively on a replacement well, Well #3, for all 
uses. Well #3 is in a wooded area approximately 500 feet west of the school and is tested 
for perchlorate as required by MassDEP regulations (D. Cabral, MassDEP Western 
Region, Drinking Water/Municipal Services Section Chief, personal communication, 
June 2012).   
Because of the historical contamination in the Mount Greylock Regional School’s wells, 
residents have expressed concerns about possible impacts on the health of students 
attending the school and staff working at the school when the wells were contaminated 
with perchlorate. In particular, the concerns have focused mainly on thyroid cancer and 
other thyroid diseases.  To address these concerns, this report summarizes 27 years of 
thyroid cancer incidence data for the four communities served by the school and 
evaluates the potential health risks associated with exposure to perchlorate based on 
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available perchlorate sampling data from 2004 and 2005.  It is important to point out that 
the consensus of experts who evaluate the carcinogenic potential of chemicals is that, 
while perchlorate can impact thyroid hormonal levels, it is unlikely that perchlorate poses 
a risk of thyroid cancer in humans (National Research Council 2005). Perchlorate is of 
health concern because it interferes with iodide uptake in the thyroid gland and can 
therefore impact the normal function of the thyroid which produces important hormones. 
Thyroid hormones regulate metabolic processes throughout the body and are critical to 
developing fetuses and infants. In this evaluation, the potential health risks associated 
with the ingestion of school well water are evaluated based on what is known about 
perchlorate’s toxicity to the thyroid gland. 
IV. EVALUATION OF HEALTH RISKS FROM INGESTION OF DRINKING 
WATER CONTAINING PERCHLORATE 
To evaluate concerns about potential historical exposures to perchlorate from drinking 
water drawn from the wells at the Mount Greylock Regional School, the MDPH reviewed 
the sampling data contained in the MassDEP’s report titled The Occurrence and Sources 
of Perchlorate in Massachusetts (MassDEP 2006a). The concentrations of perchlorate 
detected in Wells #1 and #2 at the high school in 2004 and 2005 are presented in Table 1. 
For Well #1, concentrations of perchlorate detected from the eight samples collected and 
analyzed ranged from 5.05 μg/L to 11 μg/L.  For Well #2, concentrations of perchlorate 
detected from eight samples ranged from 0.46 μg/L to 2.8 μg/L. The average and 
maximum concentrations of perchlorate in the two wells combined are 4.9 μg/L and 11 
μg/L, respectively. As mentioned previously, after the initial test results, bottled water 
was supplied to the school to prevent future exposure opportunities to perchlorate in the 
water.  
No federal drinking water standard currently exists for perchlorate. Standards or 
guidelines across the country for perchlorate in drinking water range from 2 μg/L (in 
Massachusetts) to 18 μg/L (in Nevada). Differences between individual state standards or 
guidelines include different exposure assumptions (for example, MassDEP assumes that 
drinking water is the source of 20 percent of a person’s total perchlorate exposure) and 
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differences in scientific opinion about the level of perchlorate exposure unlikely to result 
in adverse health effects even for sensitive populations. It should be noted that standards 
or guidelines are intentionally set to be well below those levels where health effects 
might occur even in the most sensitive populations, as determined by human or animal 
studies (that is, typically, at least 10 to 100 times lower than an effects level). 
The USEPA Integrated Risk Information System (IRIS) has classified perchlorate as not 
likely to be carcinogenic to humans (USEPA 2012). This is consistent with the 
conclusion of the National Research Council in its document entitled Health Implications 
of Perchlorate Ingestion in which a committee, established to study the health 
implications of perchlorate ingestion, concluded that it is unlikely that perchlorate poses a 
risk of thyroid cancer in humans (National Research Council 2005).  
To evaluate the potential health risks associated with exposure to perchlorate in drinking 
water drawn from Wells #1 and #2 at the Mount Greylock Regional School, MDPH made 
conservative assumptions to estimate the doses that school employees and students could 
have received if they consumed the maximum and average detected concentrations of 
perchlorate in the well water.  For example, we assumed both students and staff would 
drink one liter of water from the school every day of the school year (180 days for 
students; 250 days for school administrative staff who work year-round). We also 
assumed that exposures occurred for 6 years for students and 15 years for staff (which is 
the maximum number of years of potential exposure assuming that contamination began 
after fireworks were used in 1989). Assuming exposure to the average detected 
concentration of perchlorate (4.8 μg/L), noncancer health effects would not be expected. 
The estimated exposure doses for staff and students are below the reference dose of 0.07 
μg/kg/day used in the development of the MassDEP drinking water standard for 
perchlorate.  Although the estimated exposure doses associated with the maximum 
detected concentration of perchlorate (11 μg/L) slightly exceed the reference dose (0.11 
μg/kg/day versus 0.07 μg/kg/day), noncancer health effects would not be expected even 
at the maximum concentration because of the uncertainty/safety factor of 100 applied to 
the reference dose.  This factor was applied to provide a margin of safety to the reference 
dose. See Appendix A for the exposure dose calculations.   
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V. ANALYSIS OF CANCER INCIDENCE 
Thyroid cancer incidence rates were calculated for the communities of Hancock, 
Lanesborough, New Ashford, and Williamstown2. Rates for five time periods were 
calculated: 1982-1986, 1987-1991, 1992-1996, 1997-2001, and 2002-2008.  The year 
1982 represents the first year that data from the Massachusetts Cancer Registry (MCR) 
became available. The most current year for which complete data were available at the 
initiation of this analysis is 2008.  Therefore, 27 years of cancer incidence data were 
reviewed in this analysis.     
A. Methods for Analyzing Cancer Incidence 
The MCR is a population-based surveillance system that began collecting information in 
1982 on Massachusetts residents diagnosed with cancer.  Massachusetts law requires all 
new cancer diagnoses among residents to be reported to the MCR within six months of 
the date of diagnosis (M.G.L. c.111. s 111b).  This information is kept in a confidential 
database.  Data are collected on a daily basis and are reviewed for accuracy and 
completeness.  This process corrects misclassification of data (for example, incorrect 
city/town assignment).  Once these steps are finished, the data for that year are 
considered “complete”.  Due to the volume of information received by the MCR, the 
large number of reporting facilities, and the six-month period between diagnosis and 
required reporting, the most current registry data that are complete will inherently be a 
minimum of two years prior to the current date.  The year 2008 constitutes the most 
recent and complete cancer incidence data available at the time of this analysis.      
 
The term "cancer" is used to describe a variety of diseases associated with abnormal cell 
and tissue growth.  Cancers are classified by the location in the body where the disease 
originated (the primary site) and the tissue or cell type of the cancer (histology).  
Epidemiologic studies have revealed that different types of cancer are individual diseases 
with separate causes, risk factors, characteristics and patterns of survival (Berg 1996).  
Therefore, it is appropriate to evaluate each type of cancer separately.  Cancers that occur 
                                                          
2 The ICD-O-3 code used to identify thyroid cancer diagnoses in this report is: C73.9 (primary site) and all 
histology codes except 9590 – 9989 (International Classification of Diseases for Oncology, 3rd edition). 
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as the result of the metastasis or the spread of a primary site cancer to another location in 
the body are not considered as separate cancers and therefore were not included in this 
analysis.  
 
It should be noted that any duplicate records included in the MCR data were eliminated 
from analyses in this report.  Duplicate cases are additional reports of the same primary 
site cancer diagnosed in an individual by another health-care provider.  The decision that 
a case was a duplicate and should be excluded from the analyses was made by the MCR 
after consulting with the reporting hospital/diagnostic facility and obtaining additional 
information regarding the histology and/or pathology of the case.  However, reports of 
individuals with multiple primary site cancers were included as separate cases in this 
report.  In general, a diagnosis of a multiple primary cancer is defined by the MCR as a 
new cancer in a different location in the body or a new cancer of the same histology (cell 
type) as an earlier cancer, if diagnosed in the same primary site (original location in the 
body) more than 2 months after the initial diagnosis (MCR 2003).   
To assess whether the incidence of thyroid cancer is unusual, a statistic called the 
standardized incidence ratio (SIR) was calculated using data from the MCR.  The SIR is a 
comparison of the number of diagnoses in the community to the number of expected 
diagnoses based on the statewide rate.  Specifically, an SIR is the ratio of the observed 
number of cancer diagnoses in an area to the expected number of diagnoses multiplied by 
100.  Age-specific statewide incidence rates were applied to the population distribution of 
the community to calculate the number of expected cancer diagnoses.3   
An SIR of 100 indicates that the number of cancer diagnoses observed in the population 
being evaluated is equal to the number of cancer diagnoses expected.  An SIR greater 
than 100 indicates that more cancer diagnoses occurred than expected and an SIR less 
than 100 indicates that fewer cancer diagnoses occurred than expected.  Accordingly, an 
SIR of 150 is interpreted as 50% more diagnoses than the expected number; an SIR of 90 
indicates 10% fewer diagnoses than expected.  To help interpret an SIR, the statistical 
                                                          
3 Using different population estimates or statistical methodologies, such as grouping ages differently or 
rounding off numbers at different points during calculations, may produce results slightly different from 
those published in this report.  
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significance of an SIR can be assessed by calculating a 95% confidence interval (CI) to 
determine if the observed number of diagnoses is “statistically significantly different” 
from the expected number or if the difference may be due solely to chance (Rothman and 
Boice 1982).  When an SIR is statistically significant, there is less than a 5% percent 
chance that the observed difference (either increase or decrease) in the rate is the result of 
random fluctuation in the number of observed cancer diagnoses.  It should be noted that 
SIRs and 95% CIs are not calculated when the observed number of diagnoses is fewer 
than five.  Appendix B provides a more detailed explanation of SIRs and 95% CIs.  
In addition to calculating SIRs, residence at diagnosis was mapped for individuals 
diagnosed with thyroid cancer in the four communities over the 27-year period. This was 
done to evaluate the spatial pattern of diagnoses in the communities.  
 B.  Results of Cancer Incidence Analysis 
Tables 2 through 6 summarize the incidence of thyroid cancer for the communities of 
Hancock, Lanesborough, New Ashford, and Williamstown for the five time periods 
evaluated.  In the results summarized below, thyroid cancer incidence is first reported by 
individual community and then for the four communities combined. 
For the two communities of Hancock and New Ashford, no diagnoses of thyroid cancer 
were observed during the 27-year time period.  For Hancock, approximately 1.7 
diagnoses would be expected based on the statewide experience for thyroid cancer and 
the population of Hancock.  For New Ashford, approximately 0.6 diagnoses would have 
been expected.  
For the community of Lanesborough, five diagnoses were observed over the 27-year 
period when approximately 6.7 diagnoses would be expected. In four of the five time 
periods, the incidence of thyroid cancer in Lanesborough was approximately as expected 
or less than expected. In the earliest time period, 1982-1986, one diagnosis was observed 
in males when approximately 0.2 diagnoses would be expected. 
For the community of Williamstown, 14 diagnoses were observed over the 27-year 
period when approximately 16.6 would be expected.  For the three most recent time 
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periods, covering 1992 through 2008, for both males and females, the number of 
observed diagnoses was consistently less than the number expected.  For 1982-1986, no 
males were diagnosed with thyroid cancer while two females were diagnosed when 
approximately 0.9 diagnoses would be expected.  For 1987-1991, one male was 
diagnosed with thyroid cancer when approximately 0.5 diagnoses were expected.  For 
females during this same time period, two diagnoses were observed when approximately 
one diagnosis would have been expected.  
When examined by time period, the incidence of thyroid cancer in the four communities 
combined was approximately as expected for the three most current time periods: 1992-
1996, 1997-2001, and 2002-2008.  In the earliest time period, 1982-1986, no diagnoses 
were reported in Hancock or New Ashford while, in Lanesborough and Willamstown, 
one additional diagnosis occurred over what would be expected. In Lanesborough, one 
male was diagnosed with thyroid cancer when approximately 0.2 diagnoses would be 
expected; no diagnoses were observed in females.  In Williamstown, two diagnoses were 
observed in females when 0.9 diagnoses would be expected; no diagnoses were observed 
in males.  In the following time period, 1987-1991, no diagnoses were reported in 
Hancock, Lanesborough, or New Ashford.  In Williamstown, one diagnosis occurred in 
males when approximately 0.5 diagnoses would be expected.  In Willamstown females 
during this time period, two diagnoses were observed when approximately 1.1 diagnoses 
would be expected. 
For each time period and community, the geographic distribution of the place of 
residence at the time of diagnosis was generally consistent with the population density in 
each community. 
VI. DISCUSSION 
At the request of some concerned residents, the MDPH conducted an evaluation of the 
incidence of thyroid cancer in the four communities of Hancock, Lanesborough, New 
Ashford, and Williamstown. This request was prompted by concerns about health 
conditions/disease, particularly thyroid cancer and thyroid disease(s), being potentially 
related to historical exposure to perchlorate-contaminated drinking water at the Mount 
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Greylock Regional School. Perchlorate contamination was discovered in 2004 in two 
wells that previously supplied drinking water to staff and students at the Mount Greylock 
Regional School. Bottled water was used at the school for drinking and cooking once the 
perchlorate contamination was discovered. It is not known how long the perchlorate may 
have been in the well water, however, fireworks were launched from the school grounds 
between 1989 and 1992 and from 1999 to 2003 and were presumed to be the source of 
the perchlorate (MassDEP 2006a). Therefore, assuming that the fireworks were the 
source of the perchlorate in the well water, it is possible that the wells became 
contaminated with perchlorate sometime between 1989 and 2004. 
The thyroid gland is the target organ of perchlorate toxicity. Perchlorate interferes with 
iodide uptake by the thyroid gland and can disrupt the synthesis of thyroid hormones 
critical to normal growth, development, and other physiological functions (Zewdie et al. 
2010).  As discussed earlier, although perchlorate can adversely affect the thyroid gland 
in sufficient doses, it is not thought to be likely to cause thyroid cancer (NRC 2005; 
USEPA 2012). MDPH’s review of thyroid cancer incidence data was intended to address 
the concerns of some residents of a perceived increase in the incidence of this type of 
cancer in their communities; however, based on the medical/epidemiological literature 
and an expert panel established by the National Research Council, the incidence of 
thyroid cancer in these communities would not be expected to be associated with the 
historical presence of perchlorate in the Mount Greylock Regional School wells.   
Appendix C contains a summary of risk factors associated with thyroid cancer. For 
reasons that are unclear, benign thyroid nodules and thyroid cancers occur almost three 
times more often in females than in males.  This was true for the four communities 
evaluated in this report as well; over the 27-year period, 14 females were diagnosed with 
thyroid cancer compared to five males. The American Cancer Society reports that thyroid 
cancer is commonly diagnosed at a younger age than most other adult cancers. Eighty 
percent of newly diagnosed thyroid cancer patients are under 65 years of age (ACS 
2012). Thyroid cancer is one of the most common cancers for individuals below 40 years 
of age. The National Cancer Institute, in its report titled Cancer Epidemiology in Older 
Adolescents and Young Adults 15 to 29 Years of Age, reported that, although uncommon, 
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thyroid cancer is not an unusual finding in the adolescent and young adult population 
(Bleyer A et al. 2006). Between 1975 and 2000, it represented approximately 7.8% of all 
cancers diagnosed in the 15- to 19-year age group, 11.5% in patients 20 to 24 years old, 
and 10.1% in individuals from ages 25 to 29. The NCI also reported that thyroid cancer is 
very rare in children younger than 15 years of age.  In the four communities over the 27-
year period, the age range at diagnosis was from 20 to over 60 years of age with 70% 
diagnosed at the ages of 35 and over.  
Established risk factors for thyroid cancer include family history, particularly for the 
medullary subtype of thyroid cancer, and certain inherited conditions such as Gardner 
syndrome, familial polyposis, or a family history of goiters with multiple thyroid nodules. 
Ionizing radiation is also an established risk factor for thyroid cancer. This does not 
include routine diagnostic x-rays that use very low doses of radiation. Exposure to high 
levels of ionizing radiation from nuclear fallout (such as at Chernobyl, Nagasaki, and 
Hiroshima) has been linked with increased incidence of thyroid cancer. In addition, high 
dose radiation associated with treatments for certain types of cancer may put an 
individual at increased risk of thyroid cancer. A diet low in iodine may increase the risk 
of the subtype called follicular carcinoma of the thyroid; because most table salt in the 
US is fortified with iodine, however, this is not thought to be a risk factor of thyroid 
cancer in this country.  
To assess the potential for noncancer health impacts in the staff and students at the Mount 
Greylock Regional School who may have consumed water contaminated with 
perchlorate, MDPH estimated the dose that an adult and an adolescent may have received 
if they were exposed to the maximum and the average of the detected concentrations of 
perchlorate from sampling in 2004 and 2005.  The estimated doses were based on 
conservative or health-protective assumptions such as a daily drinking water ingestion 
rate of one liter per day from the wells for 6 years, in the case of student, and for 15 
years, in the case of an adult staff person.   
A review of 27 years of thyroid cancer incidence data for the communities of Hancock, 
Lanesborough, New Ashford, and Williamstown showed that the incidence of thyroid 
cancer in these communities for the most part was approximately as expected during the 
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1982-2008 time period.  In addition, based on conservative exposure assumptions and 
assuming that the available data on historical perchlorate concentrations in the Mount 
Greylock Regional School wells are representative of exposures that may have occurred 
in the past, adverse health effects would not be expected.  
VII. CHILD HEALTH CONSIDERATIONS 
The MDPH recognizes that the unique vulnerabilities of children demand special 
emphasis in communities faced with contamination in their environment.  Children are at 
a greater risk than adults for certain kinds of exposure to hazardous substances in the 
environment.  Children are smaller, resulting in higher doses of contaminant exposure per 
body weight than adults.  The developing body systems of children can sustain permanent 
damage if certain toxic exposures occur during critical growth stages.   
 
The incidence and patterns of thyroid cancer among residents (of all ages) of Hancock, 
Lanesborough, New Ashford, and Williamstown are discussed in Section V (“Analysis of 
Cancer Incidence”) of this report.  As mentioned previously, the incidence of thyroid 
cancer in these communities for the 27-year period of 1982-2008 does not appear 
unusual.  
 
In addition, past exposure of adolescents attending the Mount Greylock Regional School 
between 1989 and 2004 may have been possible. However, based on the exposure 
assessment conducted for this report, adverse health effects would not be expected.   
 
VIII. LIMITATIONS 
As part of this HC, thyroid cancer incidence data were analyzed to determine whether the 
pattern or occurrence of thyroid cancer in the communities of Hancock, Lanesborough, 
New Ashford, and Williamstown is unusual.  The pattern of diagnoses of thyroid cancer 
was evaluated in a geographical context to determine whether further investigation seems 
warranted.  Information from descriptive analyses, which may suggest a common 
etiology (or cause) is possible, can serve to identify areas where further analyses may be 
needed.  Inherent limitations in the available data and this type of analysis make it 
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impossible to determine the precise causal relationships or synergistic roles that may have 
contributed to the development of individual cancers in a community.  Cancers in general 
have a variety of risk factors known or suggested to be related to the etiology of the 
disease that could not be evaluated in this investigation.  It is beyond the scope of this 
investigation to determine the causal relationship of these factors and the development of 
thyroid cancer in the four communities.  Also, this type of analysis cannot determine 
what may have caused cancer in any one particular individual.   
It is not known when Wells #1 and #2 first became contaminated with perchlorate, 
however assuming that the source of the perchlorate was fireworks used on the school 
property, then the period of exposure to perchlorate-contaminated drinking water for an 
adult employed at the school could have ranged from between one to 15 years. For a 
student, it was assumed that the period of exposure was the 6 years of attendance at the 
school.  Another uncertainty is the actual amount of water consumed by an individual 
while at the school. To be conservative, it was assumed that a liter of water was ingested 
every day at the school.  Finally, the exposure assessment in this report is based on an 
assumption that the perchlorate concentrations measured in 2004 and 2005 were 
representative of the entire period when a person may have been exposed.  No other 
sampling data are available other than the 2004 and 2005 sampling data used in this 
assessment; however, given that fireworks were launched as late as 2003, measurements 
in 2004 provide some reasonable measure of potential exposure. Based on this analysis, it 
is also not possible to predict the health risk that a particular individual may face who 
may have exposed to perchlorate; rather, this evaluation can be used to estimate 
theoretical health risks.   
IX. CONCLUSIONS 
Based on the MDPH’s evaluation of the available well water sampling data, the exposure 
assessment, and thyroid cancer incidence data, MDPH concludes that:   
 Based on available perchlorate sampling data from 2004 and 2005 for Wells #1 
and #2, which were previously used for drinking water at the Mount Greylock 
Regional School until 2004, and conservative exposure assumptions, noncancer 
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health effects would not be expected. The reason for this is because, based on 
available information and conservative assumptions about the frequency and 
duration of potential exposures, levels of perchlorate that could get into an adult’s 
or a student’s body were estimated to be below levels that would harm their 
health. 
 Within the communities of Hancock, Lanesborough, New Ashford, and 
Williamstown, the incidence of thyroid cancer over the 27-year period of 1982 
through 2008 does not appear unusual. The incidence of thyroid cancer in these 
communities was approximately as expected based on the statewide thyroid 
cancer experience.   
X. RECOMMENDATIONS 
The MDPH recommends no further investigation into historical perchlorate 
contamination associated with two former wells located on the grounds of the Mount 
Greylock Regional School and no further investigation of thyroid cancer incidence in 
Hancock, Lanesborough, New Ashford, and Williamstown at this time.   
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Figure 1.  Map of Hancock, Lanesborough, New Ashford, and Williamstown.
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Table 1. Historical Perchlorate Concentrations in Wells 1 and 2 at Mount Greylock Regional High School
Sample Collection Date
Well #1 Well #2
4/15/2004 5.05 1.03
5/6/2004 9.6 2.5
5/7/2004 9.1 2.3
5/7/2004 5.23 1.14
9/29/2004 11 1.2
10/5/2004 7.12 1.71
10/5/2004 10 2.8
2/22/2005 6.01 0.46
Concentration (μg/L)
 
 
Source:  MassDEP Draft Report The Occurrence and Sources of Perchlorate in Massachusetts, April 2006  
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Hancock 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.1 NC NC -- NC
Lanesborough 1 0.5 NC NC -- NC 1 0.2 NC NC -- NC 0 0.3 NC NC -- NC
New Ashford 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Williamstown 2 1.4 NC NC -- NC 0 0.5 NC NC -- NC 2 0.9 NC NC -- NC
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected diagnoses.
Expected number of diagnoses presented are rounded to the nearest tenth.
Obs = Observed number of diagnoses 95% CI = 95% Confidence Interval
Exp = Expected number of diagnoses NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
SIRs and 95% CIs are not calculated when the observed number is < 5.
95% CI 95% CI 95% CI
Total Males Females
Table 2
Thyroid Cancer Incidence
Selected Communities in Massachusetts
1982-1986
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Hancock 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.1 NC NC -- NC
Lanesborough 0 0.6 NC NC -- NC 0 0.2 NC NC -- NC 0 0.4 NC NC -- NC
New Ashford 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Williamstown 3 1.6 NC NC -- NC 1 0.5 NC NC -- NC 2 1.1 NC NC -- NC
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected diagnoses.
Expected number of diagnoses presented are rounded to the nearest tenth.
Obs = Observed number of diagnoses 95% CI = 95% Confidence Interval
Exp = Expected number of diagnoses NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
Table 3
Thyroid Cancer Incidence
Selected Communities in Massachusetts
1987-1991
SIRs and 95% CIs are not calculated when the observed number is < 5.
95% CI 95% CI 95% CI
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Hancock 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Lanesborough 0 0.8 NC NC -- NC 0 0.2 NC NC -- NC 0 0.6 NC NC -- NC
New Ashford 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Williamstown 1 2.1 NC NC -- NC 0 0.5 NC NC -- NC 1 1.5 NC NC -- NC
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected diagnoses.
Expected number of diagnoses presented are rounded to the nearest tenth.
Obs = Observed number of diagnoses 95% CI = 95% Confidence Interval
Exp = Expected number of diagnoses NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
SIRs and 95% CIs are not calculated when the observed number is < 5.
95% CI 95% CI 95% CI
Total Males Females
Table 4
Thyroid Cancer Incidence
Selected Communities in Massachusetts
1992-1996
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Hancock 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC 0 0.2 NC NC -- NC
Lanesborough 1 1.2 NC NC -- NC 0 0.3 NC NC -- NC 1 0.9 NC NC -- NC
New Ashford 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.1 NC NC -- NC
Williamstown 2 3.0 NC NC -- NC 0 0.7 NC NC -- NC 2 2.3 NC NC -- NC
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected diagnoses.
Expected number of diagnoses presented are rounded to the nearest tenth.
Obs = Observed number of diagnoses 95% CI = 95% Confidence Interval
Exp = Expected number of diagnoses NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
Table 5
Thyroid Cancer Incidence
Selected Communities in Massachusetts
1997-2001
SIRs and 95% CIs are not calculated when the observed number is < 5.
95% CI 95% CI 95% CI
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Hancock 0 1.0 NC NC -- NC 0 0.3 NC NC -- NC 0 0.8 NC NC -- NC
Lanesborough 3 3.6 NC NC -- NC 1 0.9 NC NC -- NC 2 2.7 NC NC -- NC
New Ashford 0 0.4 NC NC -- NC 0 0.1 NC NC -- NC 0 0.3 NC NC -- NC
Williamstown 6 8.5 70 26 -- 153 2 2.1 NC NC -- NC 4 6.5 NC NC -- NC
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected diagnoses.
Expected number of diagnoses presented are rounded to the nearest tenth.
Obs = Observed number of diagnoses 95% CI = 95% Confidence Interval
Exp = Expected number of diagnoses NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
SIRs and 95% CIs are not calculated when the observed number is < 5.
95% CI 95% CI 95% CI
Total Males Females
Table 6
Thyroid Cancer Incidence
Selected Communities in Massachusetts
2002-2008
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Exposure Dose Calculation Formulas: 
Noncancer Health Effects Exposure Factor: 
 days 365  ED
ED  F  NC_EF 
  
Noncancer Health Effects Exposure Dose: 
BW
NC_EF IR  [C]
  NC_D  waterdrinking
  
 
Where:  
   NC_EF  = Noncancer Exposure Factor (unitless) 
   F  = Frequency of Exposure (days/year) 
   ED  = Years of Exposure (years) 
   NC_D   = Noncancer Exposure Dose (ug/kg/day) 
   [C]drinking water  = Concentration in Drinking Water (ug/L) 
   IR   = Drinking Water Ingestion Rate (L/day) 
   BW  = Body Weight (kg) 
    
    
 Assumptions: 
1. The receptors evaluated were adolescents (ages 12 to 18) and adults.   
2. The average and maximum contaminant concentration detected in the Mount 
Greylock Regional School wells were assumed as the drinking water 
concentration.  
3. The amount of drinking water ingested was assumed to be 1 liter per day.  
4. The exposure factor was determined assuming students consumed drinking water 
from the wells for the entire school year for 6 years (180 days per year). For 
school staff, it was assumed that they consumed the drinking water for 250 days 
per year for 15 years; this assumes 5 days/week for 50 weeks/year and the 
maximum number of years for which exposure to contaminated water was 
assumed to have been possible.   
5. The average body weight was assumed to be as follows: adult = 70 kilograms; 
adolescent = 50 kilograms.    
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 Exposure Dose Calculations for Ingestion of Drinking Water Containing 
Perchlorate: 
 
1. Adult  
 
68.0
 days 365  years 15
years 15 days/year  250 Factor Exposure EffectsHealth Noncancer 

 
 Assuming maximum detected perchlorate concentration:
 ug/kg/day 0.11  
kg 70
0.68 L/day  1  ug/L 11  Dose Exposure EffectsHealth Noncancer   
 Assuming average detected perchlorate concentration: 
 ug/kg/day 0.047  
kg 70
0.68 L/day  1  ug/L 4.8  Dose Exposure EffectsHealth Noncancer   
 
2. Adolescent (ages 12 to 18) 
 49.0
 days 365  years 6
years 6 days/year  180 Factor  Exposure EffectsHealth Noncancer 
  
 Assuming maximum detected perchlorate concentration: 
ug/kg/day 0.11  
kg 50
0.49 L/day  1  ug/L 11  Dose Exposure EffectsHealth Noncancer   
 Assuming average detected perchlorate concentration: 
ug/kg/day 0.047  
kg 50
0.49 L/day  1  ug/L 4.8  Dose Exposure EffectsHealth Noncancer   
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To determine whether an elevation is occurring among individuals diagnosed with cancer 
in a community or census tract (CT), cancer incidence data are tabulated by gender 
according to eighteen age groups to compare the observed number of cancer diagnoses to 
the number that would be expected based on the statewide cancer rate.  Specifically, an 
SIR is the ratio of the observed number of cancer diagnoses in an area to the expected 
number of diagnoses multiplied by 100. Age-specific statewide incidence rates are 
applied to the population distribution of a community to calculate the number of expected 
cancer diagnoses.  The SIR is a comparison of the number of diagnoses in the specific 
area (i.e., community or census tract) to the number of expected diagnoses based on the 
statewide rate.  Comparison of SIRs between communities or census tracts is not possible 
because each of these areas has different population characteristics.   
 
To calculate an SIR, it is necessary to obtain accurate population information.  Population 
is interpolated based on U.S. census data for the community of interest.  Midpoint 
population estimates are calculated for each time period evaluated.  To estimate the 
population between census years, an assumption is made that the change in population 
occurs at a constant rate throughout the ten-year interval between each census.  
A CT is a geographic subdivision of a city or town designated by the United States 
Census Bureau.  Because age group and gender-specific population information is 
necessary to calculate incidence rates, the CT is the smallest geographic area for which 
cancer rates can be accurately calculated.  Specifically, a CT is a smaller statistical 
subdivision of a county as defined by the U.S. Census Bureau.  CTs usually contain 
between 1,500 and 8,000 persons and are designed to be homogenous with respect to 
population characteristics (U.S. DOC 2000).   
An SIR of 100 indicates that the number of cancer diagnoses observed in the population 
evaluated is equal to the number of cancer diagnoses expected in the comparison or 
“normal” population.  An SIR greater than 100 indicates that more cancer diagnoses 
occurred than expected and an SIR less than 100 indicates that fewer cancer diagnoses 
occurred than expected.  Accordingly, an SIR of 150 is interpreted as 50% more 
diagnoses than the expected number; an SIR of 90 indicates 10% fewer diagnoses than 
expected.   
Caution should be exercised, however, when interpreting an SIR.  The interpretation of 
an SIR depends on both the size and the stability of the SIR.  Two SIRs can have the 
same size but not the same stability.  For example, an SIR of 150 based on four expected 
diagnoses and six observed diagnoses indicates a 50% excess in cancer, but the excess is 
actually only two diagnoses.  Conversely, an SIR of 150 based on 400 expected 
diagnoses and 600 observed diagnoses represents the same 50% excess in cancer, but 
because the SIR is based upon a greater number of diagnoses, the estimate is more stable.  
It is very unlikely that 200 excess diagnoses of cancer would occur by chance alone.  As 
a result of the instability of incidence rates based on small numbers of diagnoses, SIRs 
are not calculated when fewer than five diagnoses are observed for a particular cancer 
type.    
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To help interpret or measure the stability of an SIR, the statistical significance of an SIR 
can be assessed by calculating a 95% confidence interval (95% CI) to determine if the 
observed number of diagnoses is “statistically significantly different” from the expected 
number or if the difference may be due solely to chance (Rothman and Boice 1982).  
Specifically, a 95% CI is the range of estimated SIR values that has a 95% probability of 
including the true SIR for the population.  If the 95% CI range does not include the value 
100, then the study population is significantly different from the comparison or “normal” 
population.  “Significantly different” means there is less than 5% percent chance that the 
observed difference (either increase or decrease) in the rate is the result of random 
fluctuation in the number of observed cancer diagnoses.   
For example, if a confidence interval does not include 100 and the interval is above 100 
(e.g., 105-130), then there is a statistically significant excess in the number of cancer 
diagnoses.  Similarly, if the confidence interval does not include 100 and the interval is 
below 100 (e.g., 45-96), then the number of cancer diagnoses is statistically significantly 
lower than expected.  If the confidence interval range includes 100, then the true SIR may 
be 100.  In this case, it cannot be determined with certainty that the difference between 
the observed and expected number of diagnoses reflects a real cancer increase or decrease 
or is the result of chance.  It is important to note that statistical significance alone does 
not necessarily imply public health significance.  Determination of statistical significance 
is just one tool used to interpret cancer patterns in a community. 
In addition to the range of the estimates contained in the confidence interval, the width of 
the confidence interval also reflects the stability of the SIR estimate.  For example, a 
narrow confidence interval, such as 103-115, allows a fair level of certainty that the 
calculated SIR is close to the true SIR for the population.  A wide interval, for instance 
85-450, leaves considerable doubt about the true SIR, which could be much lower than or 
much higher than the calculated SIR.  This would indicate an unstable statistic.  Again, 
due to the instability of incidence rates based on small numbers of diagnoses, statistical 
significance is not assessed when fewer than five diagnoses are observed.   
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How to Use this Factsheet 
This risk factor summary was developed to serve as a general fact sheet.  It is an 
overview and should not be considered exhaustive.  For more information on other 
possible risk factors and health effects, please see the References section. 
 
A risk factor is anything that increases a person’s chance of developing cancer.  Some 
risk factors can be controlled while others cannot.  Risk factors can include hereditary 
conditions, medical conditions or treatments, infections, lifestyle factors, or 
environmental exposures.  Although risk factors can influence the development of cancer, 
most do not directly cause cancer.  An individual’s risk for developing cancer may 
change over time due to many factors and it is likely that multiple risk factors influence 
the development of most cancers.  Knowing the risk factors that apply to specific 
concerns and discussing them with your health care provider can help to make more 
informed lifestyle and health-care decisions.   
 
For those cancer types with environmentally-related risk factors, an important factor in 
evaluating cancer risk is the route of exposure.  This is particularly relevant when 
considering exposures to chemicals in the environment.  For example, a particular 
chemical may have the potential to cause cancer if an individual inhales the chemical but  
that same chemical may not increase the risk of cancer if an individual has skin contact 
with the chemical.  In addition, the dose and duration of time one might be exposed to an 
environmental agent is important in considering whether an adverse health effect might 
be expected.   
 
Gene-environment interactions are another important area of cancer research.  An 
individual’s risk of developing cancer may depend on a complex interaction between 
their genetic make-up and exposure to an environmental agent (for example, a virus or a 
chemical contaminant).  This may explain why some individuals have a fairly low risk of 
developing cancer as a result of an environmental factor or exposure, while others may be 
more vulnerable. 
 
Key Statistics 
 
The thyroid gland is an organ at the base of the throat that makes hormones that help 
control heart rate, blood pressure, body temperature, and weight.  The American Cancer 
Society estimates 56,460 individuals will be diagnosed with thyroid cancer in the U.S. in 
2012: 43,210 in women, and 13,250 in men.  In Massachusetts, thyroid cancer accounts 
for approximately 3% of all diagnosed cancers between 2004 and 2008.  Women are 
three times more likely to develop thyroid cancer than men.  The risk of thyroid cancer is 
highest among individuals between the ages of 20 and 55.  Thyroid cancer rates have 
been increasing in Massachusetts since 1984, with significant increases since 1997.  
Between 1999 and 2003, incidence rates within Massachusetts increased by 81% for 
females and by 66% for males.  These changes mirror national increases in thyroid cancer 
incidence and are attributed to better tumor detection using fine needle aspiration biopsy, 
ultrasound, and an increase in neck palpation as part of routine medical exams.   
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Types of Thyroid Cancer 
 
The term "cancer" is used to describe a variety of diseases associated with abnormal cell 
and tissue growth.  Cancers are classified by the location in the body where the disease 
originated (the primary site) and the tissue or cell type of the cancer (histology). 
 
There are several different subtypes of thyroid cancer.  In Massachusetts, seventy percent 
of thyroid cancers are of the papillary carcinoma subtype.  The second most common 
subtype is follicular carcinoma of the thyroid (15% of thyroid cancers).  Other subtypes 
of thyroid cancer include medullary thyroid carcinoma (5-8%) and anaplastic carcinoma 
(0.5-1.5%).  While thyroid cancer is one of the most common cancers for individuals 
below 40 years of age, each subtype of thyroid cancer has a different age-specific 
incidence pattern.  Papillary carcinoma has a peak in incidence between 30 and 50 years 
of age, while follicular carcinoma has a peak in incidence among individuals between the 
ages of 40 and 60.  Anaplastic carcinomas are usually diagnosed after age 60.   
 
Established Risk Factors 
 
Each subtype of thyroid cancer may have different risk factors associated with its 
development.   
 
Hereditary Conditions 
 
Individuals with a family history of medullary thyroid cancer are more likely to develop 
this subtype.  About 20% of medullary thyroid cancers result from inheriting an abnormal 
gene.  Individuals with certain inherited medical conditions are also at higher risk of 
thyroid cancer.  Higher rates of thyroid cancer occur among people with conditions such 
as Gardner syndrome, a family history of having multiple growths on the inside of the 
colon or rectum (familial polyposis), or a family history of having goiters (swollen 
thyroids) with multiple thyroid nodules.  
 
Environmental Exposures 
 
Ionizing radiation is an established risk factor for thyroid cancer.  Numerous 
epidemiological investigations have found an elevated incidence of thyroid cancer among 
several groups of individuals treated with radiation in the early 20th century including 
children with ringworm of the scalp, infants with enlarged thymus glands, and 
adolescents with enlarged tonsils.  Exposure to nuclear fallout has been linked to 
increased thyroid cancer in both nuclear power plant accidents such as at Chernobyl and 
among atomic bomb survivors in Japan.  Individuals receiving treatment for certain 
cancers may receive ionizing radiation and be at an increased risk of thyroid cancer.  
Routine diagnostic x-rays, such as dental or chest x-rays, use very low doses of radiation, 
with their benefits usually outweighing their risks.   
 
Possible Risk Factors 
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Lifestyle Factors 
 
A diet low in iodine may increase the risk of follicular carcinomas.  However, this is not 
generally considered a cause of thyroid cancer in the United States as most table salt is 
fortified with iodine.   
 
Other Risk Factors That Have Been Investigated 
 
Few other risk factors for thyroid cancer are known.  No consistent findings have been 
found among studies exploring the association of thyroid cancer with oral contraceptive 
use, age at menarche, parity (number of pregnancies), and diet.  
 
Thyroid Cancer in Children 
 
From 1975 to 1995, national incidence rates of thyroid carcinoma were practically 
negligible in very young children but substantially higher among 15-19 year olds, 
particularly for females.  Exposure to ionizing radiation in childhood appears to be more 
strongly linked with the development of thyroid cancer than exposure in adulthood.   
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